Vitality Watch

Dossier pubmed review 20-sep-2026
Narrative review or expert overview without new data

Panvascular aging: The pioneer organ hypothesis, research models and future directions.

Key claim: The integrated circulatory network, especially the aortic arch, ages early and acts as a pioneer organ that propagates senescence systemically via secretory factors, extracellular vesicles, and impaired translation, thereby driving multi-organ aging.

Abstract

Traditional vascular aging research has predominantly focused on isolated pathologies in single vascular beds, which fails to explain the synchronized functional decline of multiple organ systems that defines organismal aging. While the panvascular aging paradigm has emerged as a transformative framework for understanding systemic aging, the field remains fragmented by inconsistent phenotypic definitions, arbitrary model selection, and a critical disconnect between basic mechanistic insights and clinical translation. Recent landmark investigations-including single-cell transcriptomic profiling of primate arterial aging, comprehensive multi-omics analyses of 30 tissues across the lifespan in non-human primates, and the development of the first human vascular organoid model of premature aging-have provided compelling molecular and temporal evidence supporting the pioneer organ hypothesis of aging. These studies suggest that the integrated circulatory network may represent an important regulatory hub influencing systemic aging trajectories, with the aortic arch exhibiting accelerated molecular alterations initiating as early as the third decade of life, preceding functional deterioration in major visceral organs. Senescence propagates globally via vascular-specific secretory factors, extracellular vesicles (EVs), and impaired protein translation efficiency, driving synchronous dysfunction across the entire circulatory tree. This review addresses three critical unmet needs in the field. First, it establishes the first minimum diagnostic criteria for panvascular aging phenotypes, aligned with the latest VascAgeNet (Network for Research in Vascular Ageing) consensus, to prevent conceptual dilution and standardize cross-study comparisons. Second, it develops a problem-oriented model selection matrix that integrates cutting-edge three-dimensional human vascular organoids, multi-organ chip systems, and non-human primate models, providing actionable guidance for preclinical research design. Third, it systematically delineates the hierarchical mechanistic cascade by which panvascular aging drives multi-organ functional decline, identifies conserved core regulators of vascular senescence, and outlines a subtype-specific translational roadmap for vascular rejuvenation. By synthesizing fragmented knowledge into a cohesive, evidence-based framework, this work bridges the gap between basic research and clinical practice, and accelerates the implementation of the global VascAgeNet Roadmap.

Why this matters

The ‘pioneer organ’ framing inverts the usual reading of vascular aging as a downstream victim of systemic decline and casts the circulatory network — with the aortic arch as its earliest node — as an upstream sender of senescence via secretory factors, extracellular vesicles, and translation defects. If it holds, the vasculature becomes both a very early biomarker window and a plausibly high-leverage intervention target for multi-organ aging, though the evidence base here is a conceptual synthesis of preclinical and organoid data, not human outcome trials.

Source

Link

Briefing card

Panvascular aging: The pioneer organ hypothesis, research models and future directions.
Stage: review · pubmed · 20-sep-2026

If you follow vascular-aging biomarkers, this review argues aortic and endothelial signals may show up earlier than other organ-specific aging readouts — but the framework is a preclinical/organoid synthesis, not a clinical test.

The integrated circulatory network, especially the aortic arch, ages early and acts as a pioneer organ that propagates senescence systemically via secretory factors, extracellular vesicles, and impaired translation, thereby driving multi-organ aging.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.arr.2026.103378

build build 880 · 2bcef25 · 2026-11-18